Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of adjuvanted and non-adjuvanted H5N1 influenza vaccines in adults
2006-004063-66Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Audenz and influenza vaccine in influenza (3 arms), sponsored by Chiron Corporation. Primary endpoint: Immunogenicity according to CPMP criteria. Started Nov 2006; status: completed.
02
Drugs
Audenzinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-004063-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004063-66.